| Bioactivity | ML261 is a hepatic lipid droplets formation inhibitor with an IC50 value of 69.7 nM. ML261 can be used for the research of non-alcoholic fatty liver disease (NAFLD) and inflammation[1]. | ||||||||||||
| Target | IC50: 69.7 nM (hepatic lipid droplets formation) | ||||||||||||
| Invitro | ML261 (1 nM-10 μM; 24 h) affects hepatic lipid droplets formation in murine AML-12 cells[1]. Cell Viability Assay[1] Cell Line: | ||||||||||||
| Name | ML261 | ||||||||||||
| CAS | 902523-58-4 | ||||||||||||
| Formula | C20H23ClN2O3S | ||||||||||||
| Molar Mass | 406.93 | ||||||||||||
| Appearance | Powder | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Zou J, et al. Potent inhibitors of lipid droplet formation. 2014. |